VXP-32369-89133
4 vaccinations
2 coded responses
16 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 027 / MA
- Registered
- 2021-04-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-07
Dose 1 — Pfizer-BioNTech
-
2021-04-28
Dose 2 — Pfizer-BioNTech
-
2021-04-29
Registered in v-safe
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-30
- 2021-05-01
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-06-04
-
2021-06-09
Survey response — day 42, dose 2MedDRA: Fatigue, Oropharyngeal pain — Feeling: FairFree text: Sore throat, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-28
- 2021-10-27
-
2021-11-02
Dose 3 — Pfizer-BioNTech
- 2022-04-28
-
2022-09-15
Dose 4 — Moderna
- 2022-10-09
- 2022-10-22
- 2022-10-29
- 2022-12-17
-
2023-03-16
Survey response — 6 months, dose 4MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-16
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-03-17
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-07 | Pfizer-BioNTech | |
| 2 | 2021-04-28 | Pfizer-BioNTech | |
| 3 | 2021-11-02 | Pfizer-BioNTech | No |
| 4 | 2022-09-15 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-03-16 | Successful 2023-03-17 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 9 — day 42, dose 2
Symptoms: Sore throat, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release